Summary
OXSQ Chart
Oxford Square Capital Q2 Earnings Call Highlights
Oxford Square Capital NASDAQ: OXSQ reported higher net investment income and total investment income in the second quarter of 2026, while its net asset value per share declined modestly from the prior quarter. The company also expanded its CLO equity investments through secondary-market purchases and raised capital through its at-the-market equity program.
Oxford Square Capital Corp. (OXSQ) Q1 2026 Earnings Call Transcript
Oxford Square Capital Corp. (OXSQ) Q1 2026 Earnings Call Transcript
Oxford Square's 22% Yield Masks a Dangerous Math Problem
Oxford Square Capital Corp. (NASDAQ:OXSQ) advertises a yield above 22%, but the data tells a different story.
Oxford Square Capital Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1,204 | $2,095 | $1,733.76 | -$361.24 | -17.24% |
| KMT Kirk M. Tokheim Ameritas Advisory Services LLC | 2,424 | $3,223.92 | $3,539.04 | $315.12 | 9.77% |
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 1,041 | $1,889.97 | $1,613.55 | -$276.42 | -14.63% |
 Daniel Guy Ethos Financial Group LLC | 41,967 | $109,534.31 | $65,048.85 | -$44,485.46 | -40.61% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 6 | $8.87 | $9.3 | $0.43 | 4.85% |
Oxford Square Capital Corp. (OXSQ) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Oxford Square Capital Corp. ever had a stock split?
Oxford Square Capital Corp. Profile
| Capital Markets Industry | Financials Sector | Jonathan H. Cohen CEO | NASDAQ (NGS) Exchange | 69181V107 CUSIP |
| US Country | - Employees | 16 Nov 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Amplitude Surgical SA is a distinguished entity in the orthopedic surgery sphere, specializing in the development and distribution of pioneering products. Founded in 1997 and headquartered in Valence, France, the company has made substantial strides in enhancing orthopedic surgical procedures. By offering a wide array of products for primary and revision surgery, Amplitude Surgical caters to pathologies of the hip, knee, and lower extremities, with a particular emphasis on foot and ankle surgery. Their commitment to innovation and improved surgical outcomes has positioned them as a key player in the orthopedic field. Operating under the umbrella of PAI Partners since January 21, 2021, the company leverages its extensive network of distributors and agents to reach patients, surgeons, and healthcare facilities in approximately 30 countries, underscoring its global footprint and dedication to advancing orthopedic care worldwide.
Products and Services
- AMPLIVISION
A revolutionary computer-assisted surgical system designed to increase precision and improve outcomes in orthopedic surgeries. Utilizing cutting-edge technology, AMPLIVISION supports surgeons by providing real-time guidance and visualization, ensuring that procedures are conducted with the highest degree of accuracy.
- i.M.A.G.E.
This unique system represents a significant advancement in surgical instrumentation by offering single-use, made-to-measure instruments tailored to individual patient anatomy. The i.M.A.G.E. system streamlines the surgical process, ensuring that each instrument is optimally designed for the specific surgical task at hand, thereby enhancing operational efficiency and patient safety.
- E.T.O.I.L.E.
A technological platform specifically developed for anterior approaches in orthopedic surgery. E.T.O.I.L.E. is emblematic of less-invasive surgery, facilitating shorter recovery times and reduced post-surgical complications. This platform epitomizes the integration of innovation with patient care, embodying a forward-thinking approach to orthopedic surgery.
In addition to these groundbreaking systems, Amplitude Surgical SA provides a comprehensive suite of instruments tailored for the fitting of related accessories, further cementing its role as a comprehensive provider of solutions in the orthopedic surgery sector.
